S S Lau

1.1k total citations
28 papers, 958 citations indexed

About

S S Lau is a scholar working on Biochemistry, Molecular Biology and Oncology. According to data from OpenAlex, S S Lau has authored 28 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Biochemistry, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in S S Lau's work include Sulfur Compounds in Biology (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). S S Lau is often cited by papers focused on Sulfur Compounds in Biology (7 papers), Drug Transport and Resistance Mechanisms (4 papers) and Synthesis and Characterization of Heterocyclic Compounds (3 papers). S S Lau collaborates with scholars based in United States, Czechia and Netherlands. S S Lau's co-authors include Terrence J. Monks, R. J. Highet, T J Monks, Barbara Hill, J R Gillette, Walter T. Klimecki, Vincent G. Zannoni, Yelena Feinstein, Bernard W. Futscher and Ryan J. Wozniak and has published in prestigious journals such as Oncogene, Journal of Pharmacology and Experimental Therapeutics and Archives of Biochemistry and Biophysics.

In The Last Decade

S S Lau

28 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S S Lau United States	16	526	225	213	135	128	28	958
Wattenberg Lw United States	9	529 1.0×	331 1.5×	104 0.5×	143 1.1×	263 2.1×	10	1.1k
Helena Vadi Sweden	13	286 0.5×	278 1.2×	96 0.5×	134 1.0×	187 1.5×	19	663
John F. Curtis United States	15	361 0.7×	132 0.6×	232 1.1×	80 0.6×	114 0.9×	19	1.0k
Vangala V. Subrahmanyam United States	16	438 0.8×	128 0.6×	79 0.4×	74 0.5×	331 2.6×	24	1.1k
Markus J. Hunkeler United States	8	668 1.3×	163 0.7×	66 0.3×	60 0.4×	71 0.6×	8	966
Deanne M. Dulik United States	16	409 0.8×	164 0.7×	142 0.7×	120 0.9×	57 0.4×	26	710
Stephen A. Lesko United States	16	461 0.9×	103 0.5×	66 0.3×	152 1.1×	259 2.0×	23	879
Glenn F. Rush United States	19	342 0.7×	354 1.6×	112 0.5×	336 2.5×	104 0.8×	47	1.2k
Danuta Malejka‐Giganti United States	16	436 0.8×	153 0.7×	81 0.4×	94 0.7×	188 1.5×	65	776
Mitsuteru Numazawa Japan	23	1.0k 1.9×	403 1.8×	99 0.5×	171 1.3×	90 0.7×	160	2.2k

Countries citing papers authored by S S Lau

Since Specialization

Citations

This map shows the geographic impact of S S Lau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S S Lau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S S Lau more than expected).

Fields of papers citing papers by S S Lau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S S Lau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S S Lau. The network helps show where S S Lau may publish in the future.

Co-authorship network of co-authors of S S Lau

This figure shows the co-authorship network connecting the top 25 collaborators of S S Lau. A scholar is included among the top collaborators of S S Lau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S S Lau. S S Lau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cai, Wesley L., et al.. (2013). PP117—The varying effects of pentoxifylline on cyclin D1 levels and G1 phase arrest in different renal cell carcinoma cell models. Clinical Therapeutics. 35(8). e51–e51. 2 indexed citations

Wozniak, Ryan J., Walter T. Klimecki, S S Lau, Yelena Feinstein, & Bernard W. Futscher. (2006). 5-Aza-2′-deoxycytidine-mediated reductions in G9A histone methyltransferase and histone H3 K9 di-methylation levels are linked to tumor suppressor gene reactivation. Oncogene. 26(1). 77–90. 172 indexed citations

Eblin, K.E., Douglas W. Cromey, Tiffany Bredfeldt, et al.. (2006). Arsenite and monomethylarsonous acid generate oxidative stress response in human bladder cell culture. Toxicology and Applied Pharmacology. 217(1). 7–14. 64 indexed citations

Gupta, S., Heather E. Kleiner, Lynette K. Rogers, S S Lau, & Charles V. Smith. (1997). Redox stress and hepatic DNA fragmentation induced by diquat in vivo are not accompanied by increased 8-hydroxydeoxyguanosine contents. Redox Report. 3(1). 31–39. 4 indexed citations

Jeong, Jin Kwon, James Stevens, S S Lau, & Terrence J. Monks. (1996). Quinone thioether-mediated DNA damage, growth arrest, and gadd153 expression in renal proximal tubular epithelial cells.. Molecular Pharmacology. 50(3). 592–598. 21 indexed citations

Gibson, Neil W., et al.. (1995). Reactive Oxygen Species and DNA Damage in 2-Bromo-(glutathione-S-yl) hydroquinone-Mediated Cytotoxicity. Archives of Biochemistry and Biophysics. 320(1). 51–58. 40 indexed citations

Lau, S S, Heather E. Kleiner, & Terrence J. Monks. (1995). Metabolism as a determinant of species susceptibility to 2,3,5-(triglutathion-S-yl)hydroquinone-mediated nephrotoxicity. The role of N-acetylation and N-deacetylation.. Drug Metabolism and Disposition. 23(10). 1136–1142. 15 indexed citations

Davison, K. L., et al.. (1994). Metabolism of 2-(Glutathione-S-yl)Hydroquinone and 2,3,5-(Triglutathion-S-yl)Hydroquinone in the in Situ Perfused Rat Kidney: Relationship to Nephrotoxicity. Toxicology and Applied Pharmacology. 129(1). 121–132. 13 indexed citations

Rivera, María I., et al.. (1994). Metabolism and toxicity of 2-bromo-(diglutathion-S-yl)-hydroquinone and 2-bromo-3-(glutathion-S-yl)hydroquinone in the in situ perfused rat kidney.. Drug Metabolism and Disposition. 22(4). 503–510. 5 indexed citations

10.

Jones, Thomas W., et al.. (1994). Early Morphological and Biochemical Changes During 2-Br-(diglutathion-S-yl)hydroquinone-Induced Nephrotoxicity. Toxicology and Applied Pharmacology. 128(2). 239–250. 12 indexed citations

11.

Monks, T J, R. J. Highet, & S S Lau. (1990). Oxidative cyclization, 1,4-benzothiazine formation and dimerization of 2-bromo-3-(glutathion-S-yl)hydroquinone.. Molecular Pharmacology. 38(1). 121–127. 26 indexed citations

12.

Lau, S S, et al.. (1990). Cytotoxicity of nephrotoxic glutathione-conjugated halohydroquinones. Toxicology Letters. 53(1-2). 147–149. 2 indexed citations

13.

Monks, Terrence J., R. J. Highet, & S S Lau. (1988). 2-Bromo-(diglutathion-S-yl)hydroquinone nephrotoxicity: physiological, biochemical, and electrochemical determinants.. Molecular Pharmacology. 34(4). 492–500. 59 indexed citations

14.

Lau, S S, Barbara Hill, R. J. Highet, & Terrence J. Monks. (1988). Sequential oxidation and glutathione addition to 1,4-benzoquinone: correlation of toxicity with increased glutathione substitution.. Molecular Pharmacology. 34(6). 769–778. 146 indexed citations

15.

Lau, S S, et al.. (1985). Differential metabolism of arachidonic acid in human lung cancer cell lines (HLCCL). 26. 2 indexed citations

16.

Monks, Terrence J., S S Lau, R. J. Highet, & James R. Gillette. (1985). Glutathione conjugates of 2-bromohydroquinone are nephrotoxic.. Drug Metabolism and Disposition. 13(5). 553–559. 106 indexed citations

17.

Monks, T J, S S Lau, L R Pohl, & J R Gillette. (1984). The mechanism of formation of o-bromophenol from bromobenzene.. Drug Metabolism and Disposition. 12(2). 193–198. 11 indexed citations

18.

Lau, S S, T J Monks, & J R Gillette. (1984). Identification of 2-bromohydroquinone as a metabolite of bromobenzene and o-bromophenol: implications for bromobenzene-induced nephrotoxicity.. Journal of Pharmacology and Experimental Therapeutics. 230(2). 360–366. 44 indexed citations

19.

Lau, S S & Vincent G. Zannoni. (1981). Bromobenzene epoxidation leading to binding on macromolecular protein sites.. Journal of Pharmacology and Experimental Therapeutics. 219(2). 563–572. 32 indexed citations

20.

Lau, S S, Gerald D. Abrams, & Vincent G. Zannoni. (1980). Metabolic activation and detoxification of bromobenzene leading to cytotoxicity.. Journal of Pharmacology and Experimental Therapeutics. 214(3). 703–708. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact